By utilizing a rat model of severe ICAS, early stent placement was found to improve cerebral blood flow, restore blood–brain barrier (BBB) integrity, and alleviate cognitive deficits by downregulating intercellular adhesion molecule 1 (ICAM1) expression. The gene discussed is ICAM1; the disease is familial isolated congenital asplenia.